Free Trial

OKYO Pharma (OKYO) News Today

OKYO Pharma logo
Okyo Pharma announces first patient dosed in Phase 2 trial of OK-101
OKYO Pharma Says Phase 2 Study Of OK-101 Did Not Meet Primary Goal
Eyepoint Pharmaceuticals stock soars on wet-AMD trial results
OKYO Pharma raises $5.84m via share issuance
OKYO Pharma phase II dry eye trial making encouraging progress
OKYO Pharma closes $4M registered direct offering
OKYO Pharma withdraws public offer
Get OKYO Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for OKYO and its competitors with MarketBeat's FREE daily newsletter.

625,000% Gain (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

OKYO Media Mentions By Week

OKYO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OKYO
News Sentiment

0.00

0.45

Average
Medical
News Sentiment

OKYO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OKYO Articles
This Week

1

0

OKYO Articles
Average Week

Get OKYO Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for OKYO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (LON:OKYO) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners